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ARTICLE
Proteomic atlas of organ vasculopathies triggered
by Staphylococcus aureus sepsis
Alejandro Gómez Toledo1,2,12, Gregory Golden1,2,12, Alexandre Rosa Campos3, Hector Cuello 4,
James Sorrentino 5, Nathan Lewis 5,6,7, Nissi Varki2,8, Victor Nizet 9,10, Jeffrey W. Smith11 &
Jeffrey D. Esko 1,2*
Sepsis is a life-threatening condition triggered by a dysregulated host response to microbial
infection resulting in vascular dysfunction, organ failure and death. Here we provide a semi-
quantitative atlas of the murine vascular cell-surface proteome at the organ level, and how it
changes during sepsis. Using in vivo chemical labeling and high-resolution mass spectro-
metry, we demonstrate the presence of a vascular proteome that is perfusable and shared
across multiple organs. This proteome is enriched in membrane-anchored proteins, including
multiple regulators of endothelial barrier functions and innate immunity. Further, we auto-
mated our workflows and applied them to a murine model of methicillin-resistant Staphylo-
coccus aureus (MRSA) sepsis to unravel changes during systemic inflammatory responses.
We provide an organ-specific atlas of both systemic and local changes of the vascular
proteome triggered by sepsis. Collectively, the data indicates that MRSA-sepsis triggers
extensive proteome remodeling of the vascular cell surfaces, in a tissue-specific manner.
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The mammalian circulatory system is built of specializedtissues capable of specifying distinct vascular environ-ments. Due to anatomical and histological constraints, the
structure, morphology, and composition of the vasculature vary
across different organs1,2. For example, the highly specialized
blood–brain barrier (BBB) is built of continuous and rather
impermeable brain capillaries, whereas the liver sinusoids or the
kidney glomeruli are made of more permeable, discontinuous, or
fenestrated blood vessels. The endothelial glycocalyx is a cell
surface layer located at the luminal side of the blood vessels, and
is mainly composed of glycans, glycolipids, glycoproteins, and
proteoglycans3. The glycocalyx modulates organ-specific func-
tions, vascular hemostasis, and multiple aspects of innate
immunity4.
Rapid remodeling of the vascular surfaces occurs during sys-
temic inflammatory responses and sepsis5,6, with increased
degradation and shedding of glycocalyx components. Shed
material can fuel dysregulated inflammatory loops, acting as
damage-associated molecular patterns (DAMPs) or delaying
glycocalyx reconstitution by blunting growth factor signaling7.
Remodeling of the endothelial cell surface occurs during leuko-
cyte recruitment and extravasation, and leads to activation of the
coagulation and complement systems8–11. Infiltrating immune
cells and soluble plasma proteins also modulate the final make-up
of the endothelial glycocalyx.
The occurrence of multiple organ failure (MOF) is a cardinal
sign of severe sepsis or “septic shock”12–14. However, the mole-
cular mechanisms determining why certain organs are more
prone to failure than others are not fully understood. Given its
location between the blood and tissue compartments, the vascular
glycocalyx is an attractive target for therapeutic intervention to
prevent MOF in sepsis. In fact, it is possible that different vascular
beds may respond differently to septic factors since they are
equipped with unique and dynamic cell surface proteomes and
glycomes. Additionally, molecular remodeling of the vascular
surfaces could also facilitate acute and adaptive immune
responses. The ability to track these processes in vivo with tem-
poral and spatial resolution is key to understanding early events
during systemic inflammatory responses. Eventually, such
insights might facilitate the molecular classification of sepsis
subtypes based on specific pathogens and/or host vascular
responses.
Unfortunately, there is limited knowledge of the molecular
composition of the vascular glycocalyx in vivo, its variation across
different organs, and the changes that occur during disease. Most
studies reported to date rely either on specialized fixation and
staining techniques, or on indirect assays, for example tracking
the levels of selected markers of endothelial dysfunction in
plasma15–17. Proteomic approaches have also demonstrated
changes in the glycocalyx of cultured endothelial cells after
exposure to proinflammatory agents18,19. However, it is most
likely that cell-based systems do not fully recapitulate the com-
plex nature of the in vivo vascular glycocalyx due to the absence
of perivascular cells and plasma components. In fact, ~40% of the
proteins expressed on luminal endothelial cell plasma membranes
isolated from rat lungs are totally absent in cultured rat lung
microvascular endothelial cells, documenting the inadequacy of
cell culture models to duplicate the natural environment of
endothelial cells20.
Terminal systemic perfusion of animals has been used to
deliver reactive ester-derivatives of biotin to label cell surface
proteins accessible from the vascular flow21,22. This approach is
simple and effective, and depending on the chemistry of the
linkers and the perfusion conditions, it can result in the specific
labeling of tumors and identification of tumor biomarkers23. The
use of biotin facilitates downstream affinity chromatography and
can be easily interfaced with shotgun proteomics to dissect the
vascular cell surface proteome. Studies have demonstrated the
utility of these approaches to profile and quantify vascular anti-
gens in metastatic lesions in the liver and B-cell lymphomas,
using time-of-flight (TOF) mass spectrometry24,25. However, new
generation mass spectrometers with orbitrap-based technology
are now widely available, providing increased sensitivity, scan
speed, and mass accuracy compared to their predecessors. These
instruments facilitate high-resolution measurements of fragment
ions, improved proteome coverage, lower false discovery rates,
and more robust absolute and semi-quantitative proteome
analysis.
In this report, we apply a strategy based on systemic biotiny-
lation of murine tissues, streptavidin affinity chromatography and
high-resolution LC–MS/MS, all in a fully automated workflow,
achieving high-throughput and reproducibility. The method was
employed to generate a label-free semi-quantitative molecular
atlas of the murine vascular cell surface proteome at the organ
level (liver, kidney, brain, heart, and white adipose tissue) and
how it changes during methicillin-resistant Staphylococcus aureus
(MRSA) sepsis.
Results
Systemic labeling of vascular structures in murine organs. Due
to its systemic nature, a septic response is difficult to recapitulate
in vitro. Thus, a more universal approach is needed to track
proteome changes triggered by a septic insult in vivo. We
explored the labeling of murine vascular compartments using
terminal systemic perfusion with ester derivatives of biotin to tag,
purify, and identify proteins normally exposed to the vascular
flow. The labeling conditions are summarized in Fig. 1 and are
similar to methods previously reported by Rybak et al.21. We
subjected wildtype C57BL/6J mice to this procedure using sulfo-
NHS-biotin as described in the Methods section, and verified the
extent of labeling and localization of biotinylated material.
First, we harvested biotinylated organs, as well as control tissue
derived from PBS-perfused animals. Tissues were homogenized,
the homogenates run on SDS-PAGE, and tagged proteins were
detected by blotting with streptavidin. As shown in Supplemen-
tary Fig. 1, multiple protein bands were detected in the
biotinylated samples, whereas only faint bands were observed in
tissues from animals that were perfused with PBS. Tissue-specific
differences were also observed, as suggested by differential
mobility and intensity of the biotinylated protein bands detected
in kidney and heart. These differences suggested that the
accessibility and/or the composition of the vascular proteomes
might differ among the organs.
To better resolve the tissue compartments targeted by sulfo-
NHS-biotin perfusion, multiple organs were harvested, cryosec-
tioned, and stained with fluorophore-conjugated streptavidin.
Histological examination by confocal microscopy showed bioti-
nylated proteins in close association with blood vessels
(Fig. 2a–d). For example, strong streptavidin reactivity was
detected in the liver around the hepatic central veins and the
sinusoidal microvasculature, but not in association with par-
enchymal hepatocytes (Fig. 2a). In the kidney, biotinylated
material was restricted to the glomerular compartments and
proximal tubule (Fig. 2b). In the heart (Fig. 2c) and brain
(Fig. 2d), streptavidin reactivity localized primarily within the
microvasculature, with no obvious penetration into deeper
parenchymal regions.
To determine if the biotin labeling was specifically associated
with endothelial cell surfaces, co-staining with Isolectin B4 (IB4)
was performed (Fig. 2a–d). IB4 is a glycoprotein derived from the
African legume Griffonia simplicifolia that recognizes terminal
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12672-x
2 NATURE COMMUNICATIONS |         (2019) 10:4656 | https://doi.org/10.1038/s41467-019-12672-x | www.nature.com/naturecommunications
alpha-linked galactose residues on the carbohydrates lining the
endothelial lumen. Partial overlap between the streptavidin and
the IB4 staining patterns was observed in all tissues, confirming
the presence of biotinylated material on the endothelial lumen.
However, strong streptavidin reactivity was also detected at the
basement membrane, and within the adjacent extracellular matrix
(ECM) of the endothelial cells. Intracellular staining remained
low, confirming the inability of sulfo-NHS-biotin to penetrate the
cell membrane due to the charged character of its sulfate
functionality.
Shared and organ-specific vascular proteomics signatures. To
qualitatively explore the scope of the systemically labeled vascular
proteome, two major organs (liver, kidney) were homogenized
and subjected to streptavidin enrichment and trypsinization.
Peptide digests were analyzed through an online 2D-LC-MS/MS
workflow at high/low pH, as described in the Methods section, to
perform deep fractionation of the samples and to increase pro-
teome coverage. Briefly, samples were first separated by reverse-
phase chromatography on a C18-column at pH 10 and five
consecutive fractions were collected by eluting at increasing
acetonitrile concentrations (17%, 19.5%, 22%, 26% and 65%). The
individual fractions were then separated at pH 3 on a C18-
column and analyzed by LC-MS/MS (Fig. 3a, b). Matching con-
trol tissue from PBS-perfused animals was subjected to the same
analytical procedure to account for background signals (i.e. non-
biotinylated proteins that non-specifically interact with the
streptavidin beads). Only peptides displaying at least a 2-fold
enrichment compared to the PBS background of the respective
organ were considered for further analysis. To add more strin-
gency, a positive protein identification required a minimum of
two unique peptides with two MS/MS scans each. The complete
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Fig. 2 Protein biotinylation is primarily associated with vascular
compartments. Murine tissues from animals perfused with sulfo-NHS-
biotin were excised and subjected to cryosectioning, followed by
histological analysis using fluorescently labeled streptavidin. Cryosections
from liver (a), kidney (b), heart (c), and brain (d) were imaged using
confocal microscopy. Most of the streptavidin reactivity was closely
associated with vascular tissue structures such as the liver sinusoid or the
kidney glomerular microvasculature. Tissue slides were also co-stained
with IB4 to visualize the endothelial lumen. Partial co-localization between
streptavidin and IB4 stains indicated incorporation of biotin into the
endothelial glycocalyx but also in the nearby extracellular matrix and the
vascular extracellular space. Histological analysis was conducted in
biological triplicates, but only representative slides are shown. CV: hepatic
central veins, S: sinusoids, G: glomeruli, PT: proximal tubules, MV:
microvasculature. Scale bar, 20 μm
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Fig. 1 Workflow for in vivo biotinylation of vascular antigens. Animals were
first perfused with saline (PBS) to remove blood, followed by biotinylation
using an isotonic solution of sulfo-NHS-biotin. Unreacted NHS-groups were
quenched by perfusion with a Tris-HCl buffer (pH 7.4). All buffers were
kept ice-cold and the perfusion times were kept as short as possible to
minimize potential tissue damage and disruption. After biotinylation,
multiple organs were harvested and preserved for histological analysis, or
immediately homogenized and subjected to proteomics analysis
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Fig. 3 Online 2D-LC-MS/MS proteomics analysis of liver and kidney proteins. Biotinylated proteins from one liver and one kidney samples were enriched
on streptavidin columns, trypsinized and subjected to an online 2D-LC-MS/MS workflow on a C18 column at high/low pH. Total ion chromatograms for 5
consecutive fractions from liver (a) and kidney (b) peptide digests are shown, indicating that proteins eluting from the C18 column at high pH and at
increasing acetonitrile concentrations display different chromatographic behaviors when separated at low pH, consistent with an orthogonal fractionation
strategy. Venn diagrams showing unique and shared protein components (c). Hypergeometric enrichment test for subcellular localization showed
significant enrichment for proteins located in the cell membrane and extracellular matrix in both liver (d) and kidney (e). Functional enrichment analysis of
shared proteome signatures is shown in (f)
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bioinformatic treatment of the data was performed as detailed in
the Methods section.
After filtering the data, 409 non-redundant proteins were
identified in the liver and 533 proteins were detected in kidney
samples, at a 1% false discovery rate (Fig. 3c and Supplementary
Data 1). A number of proteins (138) were shared between the
tissues. We analyzed the subcellular localization of all protein
identifications using hypergeometric enrichment tests on their
associated Gene Ontology (GO) terms. In both liver and kidney
datasets, we found a significant enrichment for proteins
associated with the plasma membrane and the extracellular
matrix (Fig. 3d, e). This shared proteome included cadherins and
cadherin-like proteins, integrins, collagens, laminins, proteogly-
cans, cellular receptors, and enzymes as well as a large repertoire
of receptor-type protein tyrosine phosphatases (Supplementary
Data 1). Classical endothelial markers such as VE-cadherin,
endoglin, vascular cell adhesion molecule 1 (VCAM1), and
intercellular adhesion molecule 1 (ICAM1) were also identified.
Functional enrichment analysis of this signature retrieved path-
ways associated with cell adhesion, vascular morphogenesis,
proteoglycan metabolism, and vascular endothelial growth factor
(VEGF)-signaling pathways (Fig. 3f).
Unique organ-specific proteomic signatures were also detected.
For example, liver samples were characterized by the presence of
multiple scavenger receptors such as C-type lectin family 4 F
(Clec4F), Scavenger Receptor Class B Member 1 (Scarb1), stabilin
1 (Stab1), Stab2, and asialoglycoprotein receptor 2 (Asgr2),
reflecting the filtering functions of the hepatic reticuloendothelial
system (Supplementary Data 1). We also found a number of
proteins involved in lipoprotein remodeling and clearance,
including low density lipoprotein receptor (Ldlr), angiopoietin-
related protein 3 (Angptl3), hepatic triglyceride lipase precursor
(Lipc), fatty acid binding protein 1 (Fabp1), and LDLR associated
protein 1 (Ldlrap1), consistent with the role of the liver as the
major target for lipoprotein metabolism and uptake. Clec4F is a
marker for Kupffer cells, whereas Angptl3, Lipc, and Ldlrap1 are
soluble proteins presumably bound to the glycocalyx. Similarly,
kidney samples were specifically enriched in proteins involved in
the regulation of blood pressure and fluid balance, including
components of the renin-angiotensin system, such as angiotensin
converting enzyme (Ace), Ace2, glutamyl aminopeptidase
(Enpep), and renin 2 (Ren2).
Finally, a network approach was applied to focus on potential
protein-protein associations amongst the unique vascular
proteomes. All proteins identified in each tissue were searched
through the Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) database to generate a network based on
physical and functional interactions. Only high confidence
protein–protein associations (STRING association scores >0.07)
were retained in the network. The Louvain method was used to
identify communities (or clusters) displaying a higher density of
interconnected nodes than expected by random chance26. These
clusters were further segregated via force-directed visualization
algorithms, and subjected to functional enrichment analysis.
Roughly, 33% of the liver and 31% of the kidney proteins
clustered into 4 and 5 distinct Louvain communities, respectively
(Supplementary Fig. 2a–i). Each cluster covered several func-
tional layers that were often enriched in distinct biological
processes. The results from the Louvain clustering showed a clear
pattern of functional commonalities between the biotinylated
tissues. Interestingly, some of the clusters were enriched in
organ-specific processes such as signaling through receptor
tyrosine kinases and glutathione metabolism in the kidney
(Supplementary Fig. 2b, e), or regulation of lipid metabolic
pathways and lipoprotein particle clearance in the liver
(Supplementary Fig. 2h).
MRSA-sepsis results in profound liver vasculopathy. Since
sepsis is a systemic syndrome of vascular dysfunction, we rea-
soned that tracking specific molecular changes at the blood/tissue
interface could generate new insights into sepsis-associated vas-
culopathies. To explore this idea, a proteomics workflow was
applied to a murine model of sepsis triggered by MRSA bacter-
emia. Briefly, wildtype C57BL/6J mice were intravenously infec-
ted through the retroorbital route with 5 × 107 colony-forming
units (cfu) of MRSA, a model that induces lethality within 48 h
post-infection27, or with PBS as a control. Since changes in the
vascular compartments are expected to precede organ damage
and lethality, we focused on the early pre-mortality stages of the
disease 24 h post-infection28.
Analysis of the pathogen burden at this time point revealed
dramatically different bacterial invasion and/or colonization
across tissues. Liver, kidney, and heart samples exhibited the
highest pathogen infiltration, followed by brain and WAT (Fig. 4a
and Source Data File). Gross pathology of the liver showed white
necrotic plaques that were completely absent in control animals
(Fig. 4b), in line with previously published findings29. To confirm
that the hepatic pathogen burden was linked to ongoing liver
failure, we measured plasma levels of liver markers alanine
aminotransferase (ALT) and aspartate aminotransferase (AST).
Indeed, both markers were increased at 24 h post-infection
(Fig.4c and Source Data File).
To obtain a global picture of the organ pathologies, multiple
infected and uninfected tissues were subjected to histopatholo-
gical analysis. Examination of hematoxylin and eosin (H&E)
stained tissues revealed different degrees of inflammation,
bacterial colonization and tissue damage across organs (Supple-
mentary Fig. 3a–j). Liver tissues stood out from the others by
showing more leukocyte infiltrates, more bacterial microabscesses
and severe signs of necrotic thrombosis (Fig. 4d). Pathological
hypercoagulation was characterized by the presence of large
thrombi in the major veins of the liver, leading to blood vessel
occlusion and disseminated tissue necrosis. Necrotic loci spread
out over large areas adjacent to the thrombotic zones, and the
thrombi were surrounded by layers of polymorphonuclear cells.
To assess the suitability of the biotinylation perfusions for the
analysis of vascular alterations during sepsis, liver cryosections
from animals challenged with MRSA and systemic biotinylation,
were probed with fluorescently labeled streptavidin. As shown in
Fig. 4e, streptavidin reactivity was detected in areas of
thrombosis, around the blood vessels and at the surface of
infiltrating immune cells. Notably, the thrombi were also
intensely stained, whereas regions of tissue necrosis were
streptavidin negative, consistent with occluded blood perfusion
into those areas.
Proteomics profiling of vascular surfaces during sepsis. Given
that the biotinylation perfusion was able to label protein targets
within these key vasculopathic regions, the proteomics workflow
was expected to render a molecular snapshot of the septic organ
vasculatures, including the injured hepatic surfaces. For each
experiment, 3 MRSA-infected and 3 uninfected mice were anes-
thetized and subjected to the systemic biotinylation protocol at
24 h post-infection. In addition, one infected and one uninfected
mouse were perfused only with saline to account for potential
background signals. Five different organs were selected for pro-
teomics analysis based on their clinical relevance: liver, kidney,
heart, brain, and white adipose tissue (WAT). In total, we per-
formed four independent experiments resulting in a total of 160
LC-MS/MS runs. The samples were quantified using the MS
label-free strategy described above. To minimize variability
introduced by manual sample handling, the workflow was fully
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automated by transferring all sample preparations to a BRAVO
liquid handling platform. To speed up the process and to be able
to perform relative quantification, all samples were analyzed
using a single run LC-MS/MS, instead of the 2D-LC-MS/MS
approach used for deep fractionation. However, since sepsis is
notoriously heterogenous, we also applied strict bioinformatic
and statistical criteria to only focus on robust and reproducible
changes, as specified in the method section.
The proteomics screening identified robust and reproducible
alterations of a few hundred of proteins from each individual
organ (liver: 272, kidney: 300, heart: 275, WAT: 185, and brain:
85), according to a two-way analysis of variance (ANOVA) with a
permutation-based false discovery rate correction for multiple test
comparisons. The relative protein quantification for each organ is
summarized in Supplementary Data 2. Missing values were
addressed by requiring a cut-off corresponding to 75% valid
values in at least one group (infected+ biotin, uninfected+
biotin, or PBS controls). Profile plots of proteins complying to
strict criteria (see Methods) are shown in Supplementary
Fig. 4a–e. In general, the identified proteome changes covered a
wide dynamic range. Notable interassay and intraassay variability
was also observed across the samples as judge by profile plots of
their Label-Free Quantification (LFQ)- normalized intensities
(Supplementary Fig. 4a–e, upper panels). Nevertheless, plotting
the LFQ-profiles of the top 10 proteins ranked by fold change
(Supplementary Fig. 4a–e, lower panels), showed a clear
separation between infected and non-infected samples in all
tissues, indicating that the method can detect quantitative
differences triggered by sepsis.
Closer inspection of the LFQ-normalized intensities showed
strong correlations for replicates in the same group. For example,
proteins identified across three infected livers, displayed high
Pearson correlation coefficients (r= 0.93, 0.96 and 0.96)
(Supplementary Fig. 5a), whereas correlations decreased when
comparing infected vs non-infected controls (r= 0.91, 0.84, and
0.77) (Supplementary Fig. 5b). Even lower correlations were
observed when comparing biotinylated samples with non-labeled
PBS controls, independently of their infection status (infected vs.
PBS, r= 0.62, 0.69, and 0.62; uninfected vs. PBS, r= 0.56, 0.71,
and 0.74) (Supplementary Fig. 5c, d). Similar results were found
in other tissues indicating that the identity of the proteome
accessible through systemic biotinylation differs dramatically
from uninfected and PBS-perfused tissues. More importantly,
these findings also indicate that the methodology captures
differences specifically associated with infection.
Global and organ-specific proteome changes. A comparative
view of the proteomic changes taking place across the five organs
revealed a consistent organ-specific hierarchy (Fig. 5). In liver,
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Fig. 4 The murine model of MRSA-sepsis has a profound liver vasculopathic phenotype. Analysis of the pathogen burden expressed as colony-forming
units (CFUs) at 24 h post-infection (a). A representative image of liver gross pathology in uninfected and infected mice at 24 h post-infection shows the
presence of white areas corresponding to necrotic areas across the liver parenchyma (b). Quantification of soluble markers of liver damage alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) in serum collected 24 h post-infection (c). Hematoxylin and eosin staining of representative
liver sections from infected animals showing signs of necrosis (yellow arrow) and thrombosis (black arrows), scale bar, 100 μm. d Representative liver
section from mice challenged with MRSA, subjected to systemic biotinylation, and stained with streptavidin (green), IB4 (red) and DAPI (blue) (e). For
a and c, data was pooled from two independent experiments with n= 3 and n= 4 mice per experiment, where mice were infected but not subjected to
biotinylation perfusion. Data are represented as mean ± SD. ***p < 0.001 by two-sided Student’s t-test
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kidney, and heart, many proteins were altered between infected
and non-infected samples, whereas in brain and WAT only a few
proteins showed significant changes (Fig. 5a). The liver pattern
stood clearly out from the other organs. Also, some of the hepatic
proteins that underwent dramatic changes in labeling included
lubricin/proteoglycan 4 (Prg4), macrophage receptor with col-
lagenous structure (Marco), C-X-C motif chemokine ligand 9
(Cxcl9), as well as others. We subjected the data to principal
component analysis (PCA) to determine if the organ protein
patterns combined with their LFQ-intensities could segregate the
data into meaningful groups. Liver samples were clearly separated
by PCA analysis into infected and non-infected clusters (Fig. 5b).
Kidney and brain also stratified in a similar fashion. On the other
hand, PCA analysis of WAT and heart samples did not separate
the infected and uninfected groups from each other. Unsu-
pervised hierarchical clustering of the proteomics data revealed
complex expression patterns. Heat maps generated to visualize
the clustered data showed that all tissues had large clusters of
proteins enriched or depleted by infection (Fig. 5c).
A shared group of 57 proteins was consistently found to
undergo changes in all examined organs, whereas other proteins
were changing in a tissue-specific manner (liver: 88, kidney: 75,
heart: 85, brain: 8, and WAT: 18) (Fig. 6a and Supplementary
Data 3). Functional enrichment analysis of the shared proteome
retrieved biological pathways associated with coagulation, com-
plement, ECM-remodeling, and Staphylococcus aureus infection
(Fig. 6b). This proteome signature consisted of acute phase
reactants (e.g. Hp, Saa2), members of the alternative pathway of
the complement cascade, for example complement factor b (Cfb),
Cfh, and the matrix proteins basal cell adhesion molecule (Bcam)
and nidogen 1 (Nid1). Interestingly, some of these shared
proteins experienced very large fold-changes in all organs (e.g.
fold-change of haptoglobin (HP) >100 in all tissues) whereas
other proteins had a more scattered expression, with large fold-
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Fig. 5 Changes in the vascular cell surface proteome in a murine model of MRSA-sepsis. Biotinylation perfusions were coupled to an automated shotgun
proteomics workflow to identify organ-specific vascular targets changing in a murine model of MRSA-sepsis. We performed 4 separate experiments, which
resulted in the simultaneous proteomics profiling of infected (n= 12) and uninfected (n= 12) mice across 5 major organs (liver, kidney, heart, brain, and
WAT). Differential expression analysis of proteins significantly changing during infection showed that the examined organs displayed a clear hierarchy in
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changes in one organ and modest induction in the others (e.g.
>30-fold change of alpha-1-acid glycoprotein 2 (Orm2) in WAT,
whereas ~2–6-fold in all other tissues) (Fig. 6c).
The fold-changes associated with the top 50 differential
proteins in each tissue were ranked and visualized as Circos
plots (Fig. 6d). In this representation, each protein corresponds to
one ribbon, and the width of the ribbon indicates the normalized
fold-change of an individual protein as a percentage of the
summed fold-changes of all identified proteins in a particular
organ. Strong induction of Hp was observed in all tissues
accounting for 7% of all proteome changes in the liver, 36% in
kidney, 34% in heart, 45% in brain, and 23% in WAT (Fig. 6d).
This is clearly shown in the Hp ribbon, which further divides into
5 sub-ribbons that connects back to the protein distribution of
each organ. Interestingly, the pattern of the liver was unique
because it was largely dominated by liver-specific markers, as
opposed to the other organs where the largest fold-changes were
instead associated with the shared vascular proteome. Proteogly-
can 4 (Prg4) accounted for 34% of all liver vascular surface
proteome alterations but remained undetected in the other
tissues, except for the heart where it corresponded to 1% of the
cardiac proteome changes.
We identified other tissue-specific markers, which were further
subjected to pathway enrichment analysis to delineate organ-
specific pathologies (Supplementary Fig. 6a–e and Supplementary
Data 3). In the liver, neutrophil degranulation was the most
enriched biological process, reflecting the presence of multiple
neutrophil-derived proteins such as myeloperoxidase (MPO), an
essential factor for neutrophil antimicrobial responses30,31. Other
liver-specific pathways were related to cell-adhesion, integrin
signaling, and glycosaminoglycan metabolism, especially hyalur-
onan/hyaluronic acid (HA). Kidney samples were enriched in
multiple renal adhesion proteins such as the kidney-specific
cadherin-16, nephronectin, and nephrin, as well as in markers of
renal epithelium morphogenesis (Supplementary Fig. 6b). Simi-
larly, heart-specific processes were highly enriched in proteins
related to muscle contraction and markers of hypertrophic
cardiomyopathy (HCM), reflecting potential ongoing heart failure
(Supplementary Fig. 6c). Finally, a smaller number of organotypic
proteins and hence a smaller number of differential pathways
were detected in brain and WAT tissues, compared with liver,
kidney and heart (Supplementary Fig. 6d, e).
Changes in hyaluronan turnover and recognition. As men-
tioned above, some liver-specific markers could be grouped based
on their ability to influence HA recognition and turnover. HA is a
megadalton acidic polysaccharide involved in many immuno-
modulatory processes, including recruitment of activated neu-
trophils to the liver during inflammatory responses32. Among the
proteins enriched in HA metabolism and function, we found
CD44, one of the main HA receptors that regulates leukocyte
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trafficking and extravasation; the lymphatic vessel endothelial
hyaluronan receptor 1 (Lyve1), the primary HA receptor in
lymphatic endothelium; Tmem2, an endothelial cell surface
hyaluronidase; and Prg4, a lubricating and anti-inflammatory
competitor for HA binding to CD44 (Fig. 7a)33. Notably, endo-
thelial HA binds only weakly to CD44, unless the former becomes
cross-linked to one or more of the inter-alpha-trypsin inhibitor
heavy chains32. Cross-linked HA constitutes a high-affinity ligand
for neutrophil CD44 during leukocyte extravasation in the liver
sinusoids. However, the identity of the heavy chains involved in
this modification remains unknown. At least 6 closely related
heavy chains are expressed by many cell types, but only Itih1,
Itih2, and Itih3 can be cross-linked to HA34. Interestingly, we
detected these three heavy chains in both normal and septic livers,
but no significant differences were observed regarding the levels
of Itih1 and Itih2 during infection. In contrast, a 5-fold increase
in Itih3 was consistently detected in liver samples, suggesting a
potential role in HA-maturation during liver inflammation.
Moreover, increased HA plasma levels has been identified as a
sensitive marker of glycocalyx remodeling and liver dysfunction
during sepsis35,36. Indeed, at 24 h post-infection, plasma HA
levels were elevated more than 6-fold in MRSA-infected samples
compared to controls (Fig. 7b and Source Data File).
We focused on Prg4, since this HA-binding protein displayed
the largest induction of all detected liver proteins, in all liver
replicates, and across all independent experiments (Supplemen-
tary Data 2). Also known as lubricin, Prg4 is a secreted high
molecular weight glycoprotein composed of globular domains
connected by an extended mucin region. Prg4 is abundantly
expressed in synovial fluid and its glycosylation plays an
important role in the lubrication of articular joints. Although
extra-articular expression of Prg4 is known to occur, its
physiological role or involvement in liver disease has never been
reported37.
Expression and localization studies of Prg4 by immunofluor-
escence microscopy showed dramatic increase and deposition of
Prg4 in the microvasculature of septic livers (Fig. 7c, d) compared
with uninfected control liver. Strong Prg4-immunoreactivity was
detected both in vascular and perivascular regions, in agreement
with the results from the biotinylation experiments. Of note,
Prg4-staining was also detected in the periphery of large thrombi
in the vicinity of necrotic areas, and in association with ly6G-
positive neutrophils (Fig. 7e, f). Finally, quantitative PCR analysis
of liver tissue at 12 h post-infection revealed a 4.2-fold increase in
PRG4 mRNA compared to uninfected controls (Fig. 7g and
Source Data File). Taken together, these signatures suggest that
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remodeling of HA and HA-modifying proteins is a liver-specific
phenomenon activated during MRSA sepsis.
Discussion
Remodeling of the vascular glycocalyx is a hallmark of devastat-
ing diseases such as atherosclerosis, cancer and dysregulated
inflammatory responses. Both glycocalyx shedding and repair
(remodeling) are tightly regulated by a variety of mechanisms that
can be triggered in response to physiological and/or pathological
stimuli. A mechanistic understanding of these processes has been
hampered by a general lack of tools to properly address their
molecular basis. Prior studies have demonstrated the use of sys-
temic perfusion to tag murine vascular surfaces in vivo, using
ester derivatives of biotin21,22. In principle, this delivery route
creates a window to track molecular events at the blood/tissue
interface and to gain insights into changes in the vascular pro-
teome in a broad spectrum of diseases. However, these previous
studies were based on labor-intensive protocols, with limited
reproducibility and throughput. Additionally, chemical labeling
has mainly been interfaced with off-line chromatographic
separations and low-resolution MS. Nevertheless, these techni-
ques have potential as generic tools to interrogate preclinical
models of vascular diseases such as sepsis, where multiple host
tissues are simultaneously engaged.
In the present study, we combined systemic biotinylation of
murine tissues with an automated proteomics workflow to profile
the vascular surfaces in a more robust and quantitative fashion.
Indeed, multidimensional chromatography and high-resolution
proteomics profiling of murine organs confirmed the presence of
a complex protein landscape embedded in the vascular glycoca-
lyx. In keeping with previous reports, proteins accessible to the
vascular flow comprised a large number of adhesion molecules
(including many classical endothelial markers), receptor tyrosine
kinases, enzymes, scavenger receptors, proteoglycans, and plasma
proteins. Notably, we observed the presence of a shared core
proteome, probably essential to basic vascular functions of most
tissues, along with concomitant organ-specific vascular sig-
natures. Phenotypic heterogeneity of the vasculature is a phe-
nomenon that has become widely recognized38,39. Organotypic
specification of vascular tissues allows the organs to meet basic
requirements of oxygenation, nutrient acquisition, hemodynamic
regulation, and immunosurveillance, across a wide range of local
environments. Organs such as the liver or kidney are specifically
involved in regulating the rate of exchange and/or clearance of
ions, metabolites, proteins, and bacterial toxins from circulation,
and thus some organ-specific functions need to be wired at the
vascular level. Consistent with this idea, we found proteomic
signatures specific to hepatic or renal vascular surfaces that
reflected specific functions of those organs. For example, in the
liver multiple proteins involved in lipid clearance were detected
together with a large repertoire of scavenger receptors. In con-
trast, kidney displayed proteome signatures consistent with its
role in controlling fluid balance and blood pressure. Recently,
in vivo phage display assays facilitated identification of peptides
capable of homing to specific vascular beds in vivo40. These
approaches have been useful in generating tools for targeted
delivery of compounds to specific vascular “zip codes”, and they
highlight the tremendous organotypic heterogeneity of the vas-
cular surfaces. Similarly, recent developments in single cell
sequencing have facilitated detailed profiling of the brain vascu-
lature, revealing specific molecular signatures associated with
zonation along the arteriovenous axis41.
To obtain a holistic picture of vascular changes taking place
during sepsis, we adapted a murine model of MRSA-sepsis and
subjected the animals to chemical labeling and a proteomics
workflow, selecting several organs for molecular profiling. We
constructed a label-free semi-quantitative proteomics atlas of the
murine vascular cell surface proteome at the organ level (liver,
kidney, heart, brain, and WAT), and demonstrated that a septic
insult triggered by MRSA bacteremia causes substantial remo-
deling of the vascular surfaces. More specifically, we demon-
strated that MRSA-sepsis results in enrichment of acute-phase
reactants and specific matrix proteins in the vasculature of mul-
tiple tissues. Interestingly, some of the identified proteins, such as
Hp and the serum amyloid proteins Saa1 and Saa2, have already
demonstrated predictive value for diagnosis of systemic inflam-
matory processes, including neonatal sepsis42. We also identified
alterations of an array of proteins and biological processes in
particular tissues, including potentially novel pathways associated
with hepatic HA-recognition and turnover. Our proteomics
screening singled out the liver as a hotspot for MRSA sepsis
pathology, a pattern further confirmed by blood chemistry and
histopathological evidence of liver dysfunction, necrosis and
thrombosis. The levels of many proteins in the hepatic vascu-
lature changed during infection. One in particular, Prg4, con-
sistently dominated the global pattern of proteome changes in the
liver. Prg4 can oligomerize and deposit in the superficial zone of
the articular cartilage, acting as a lubricating gel to reduce fric-
tion43. Due to the large amount of negatively charged carbohy-
drates decorating its mucin domain, Prg4 can impact the
adhesion properties of synovial cell populations, bacteria and
immune cells44. Interestingly, Pgr4 is also expressed in the liver
but a role in basic liver physiology or pathology has never been
described. Here we report that PRG4 gene expression is rapidly
induced during MRSA bacteremia, resulting in its secretion and
abundant vascular deposition in the liver. Notably, Prg4 was also
detected in association with the surface of neutrophil populations,
adhering to the edges of large necrotizing thrombi, partially
occluding the perfusion of the liver. It is conceivable that vascular
deposition of Prg4 during liver inflammation might impact the
adhesion of bacteria to the glycocalyx and influence how immune
cells such as neutrophils interact with the activated endothelium.
A mechanistic understanding of the role of Prg4 during acute
hepatic injury, and especially during MRSA sepsis, warrants
future studies.
Circulating glycocalyx fragments are most likely good markers
of organ-specific pathologies. However, we do not know if some
of the proteome alterations reported in this study can also be
detected in plasma. Plasma proteomics has been widely applied to
identify fluid biomarkers of sepsis28,45,46. One major challenge
with these analyses though is the broad dynamic range of plasma
proteins, which exceeds 10 orders of magnitude47. Profiling
molecular changes in the vascular compartment can aid in the
search for novel plasma markers by defining molecular targets
undergoing remodeling at the vascular wall. Having pre-
knowledge of what kind of candidate molecules to seek might
facilitate the application of targeted proteomic assays to the
plasma proteome to increase sensitivity and coverage. Indeed,
future studies will be directed to the validation of promising
candidates in plasma samples to assess their predictive value.
Finally, this study focused on a single time-point, but the dynamic
nature of the sepsis response can only be fully addressed with
temporal-spatial resolution. Tracking some of these markers over
time will be imperative to achieve that final goal.
Methods
Bacterial strain and preparation. Methicillin-resistant Staphylococcus aureus
(MRSA USA300 TCH1516) was originally isolated from an outbreak in Houston,
Texas and caused severe invasive disease in adolescents48. MRSA was routinely
grown at 37 °C on Todd-Hewitt agar (Difco) or in liquid cultures of Todd-Hewitt
broth (THB, Difco) with agitation (200 rpm). Bacteria were inoculated into 5 mL of
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fresh THB and incubated overnight. 400 μL of overnight culture was inoculated
into 6 mL of fresh THB and incubated to OD600= 0.4. Bacteria were centrifuged,
washed twice with PBS, and suspended in PBS at 5 × 108 cfu/mL.
Animal experiments. For MRSA infection, 8–10-week-old C57Bl/6 male and
female mice were injected i.v. through the retroorbital sinus with 100 µL PBS as a
control group or with 5 × 107 cfu (100 µL) MRSA. At 24 h post-infection, animals
were euthanized by isoflurane and immediately processed using systemic chemical
perfusions. CFU in the MRSA inoculum were enumerated by serial dilution on
Todd Hewitt Agar plates to ensure consistent CFU dosing across experiments.
Animals were housed and bred in Individual Ventilated Cages in a Specific
Pathogen Free background, in vivaria approved by the Association for Assessment
and Accreditation of Laboratory Animal Care located in the School of Medicine,
UC San Diego. All experiments were performed in accordance with relevant
guidelines and regulations following standards and procedures approved by the UC
San Diego Institutional Animal Care and Use Committee (protocol #S99127 and
#S00227M).
Systemic chemical perfusions. In vivo biotinylation was essentially conducted as
reported21 with some minor changes. Briefly, animals were anesthetized using
isoflurane in a closed chamber and a median sternotomy was performed. The left
ventricle of the heart was punctured with a 25-gauge butterfly needle (BD Vacu-
tainer) and a small cut was made in the right atrium to allow draining of perfusion
solutions. All perfusion reagents were ice-cold and were infused using a perfusion
pump (Fischer scientific). Blood components were quickly washed out with PBS for
5 min at a rate of 5 mL/min. A solution containing 100mM EZ-link Sulfo-NHS-
biotin (Thermo Fischer) in PBS, pH 7.4 was used to perfuse the animals at 3 ml/min
for 10 min. Finally, animals were perfused with the quenching solution (50mM
Tris-HCl, pH 7.4) at 3 ml/min for 5 min. Control animals were perfused in exactly
the same way but with PBS.
Organ preparations. Mouse organs were harvested and homogenized using zir-
conia/silica beads, (1 mm diameter, Biospec) in a benchtop MagNA Lyser instru-
ment (Roche). Homogenization buffer contained 5M urea, 0.25 M NaCl and 0.1%
SDS. Samples were briefly centrifuged at 16100 × g for 5 min to sediment insoluble
tissue debris. The clear supernatant was transferred to a new tube and protein was
quantified by BCA assay (Thermo Scientific) as per manufacturer instructions and
stored at −80 °C until further analysis.
SDS–PAGE and in gel western blot. Organ homogenates were resolved by
SDS–PAGE (Bis-tris 4–12%). After electrophoresis, gels were incubated with 50%
isopropanol+ 5% acetic acid for 15 min, followed by a 15 min wash with ultrapure
water. Gels were further incubated with streptavidin-IRDye680 (LI-COR Bios-
ciences) for 1 h with gentle shaking in the dark. Gels were washed three more times
for 10 min in PBS+ 0.1% Tween 20. After a last wash with PBS for 5 min, the gel
was imaged using an Odyssey Infrared Imaging System (LI-COR Biosciences).
Histological analysis and immunofluorescence. Tissues were fixed in 10% buf-
fered formalin (Fischer Chemical) for 24 h, followed by submersion in 70% ethanol
for at least 24 h. The samples were paraffin embedded and sectioned (3 µm), and
stained with hematoxylin/eosin. For immunofluorescence of perfused tissues,
organs were harvested immediately following systemic Sulfo-NHS-Biotin perfusion
and fixed in ice-cold PBS+ 4% paraformaldehyde for 18–24 h with gentle end-
over-end agitation. Fixed organs were placed in 40% sucrose solution overnight.
Saturated organs were then submerged in Optimal Cutting Temperature com-
pound (OCT) (Sakura) and flash frozen in cassettes submerged in 2-methylbutane
chilled with dry ice. Sections (20 µm) were permeabilized and stained for 1 h with 1
µg/mL Streptavidin Alexa Fluor 488 (Invitrogen) and 20 µg/mL Isolectin B4 Alexa
Fluor 594 (Thermo Fischer Scientific), followed by mounting medium containing
DAPI (Thermo Fischer Scientific). Lubricin/PRG4 Antibody (NBP1-19048, Novus
Biologicals) was diluted 1/50 and detected with secondary goat anti rabbit Alexa
Fluor 647 (A-21245, Invitrogen). Sections were mounted on glass slides under #1.5
coverslips. All Z-stacks were acquired with an inverted Zeiss LSM 880 confocal
with FAST AiryScan, using either a ×10 Plan-Apochromat 0.45NA objective or a
×40 LD LCI Plan-Apochromat 1.2NA immersion objective as indicated in the
figure legend. Images were processed using the in line AiryScan processing module
in Zen Black. For intensity comparisons, all acquisition parameters were standar-
dized to the following: Red channel 561 nm, 721 master gain, 8.7% laser power, 3.7
AiryScan parameter; Green channel 488 nm, 676 master gain, 1.2% laser power, 4.1
AiryScan parameter; DAPI channel 405 nm, 732 master gain, 3.8% laser power, 3.8
AiryScan parameter.
qPCR analysis. mRNA was isolated from whole liver extracts, reverse transcribed,
and quantitated by qRT-PCR using the following primers for murine PRG4: 5′-
CAG GAC AGC ACT CCA TGT AGT-3′ (reverse) and 5′-GGG TGG AAA ATA
CTT CCC GTC-5′ (forward). mRNA was extracted using the RNeasy Kit (Qiagen).
cDNA was synthetized using SuperScript III First-Stand Synthesis kit (Invitrogen).
Expression was quantified using the 2−ΔΔCT method and TBP was used to nor-
malize the expression of the target genes between samples.
Determination of hyaluronic acid concentration. Hyaluronan levels in plasma
were measured using a Hyaluronan Quantikine Enzyme-Linked Immunosorbent
Assays (ELISA) kit (R&D Systems) according to the manufacturer’s
recommendation.
Determination of plasma levels of ALT and AST. Blood was collected via cardiac
puncture and placed in a pro-coagulant serum tube (BD Microtainer #365967) for
4 h at room temperature. Serum was isolated by spinning the tubes at 2000 × g and
collecting the supernatant. All samples were frozen and thawed once before ana-
lysis. ALT/AST was measured on a Cobas 8000 automated chemistry analyzer
(Roche) with a general coefficient of variance of <5%.
Analysis of bacteria colony-forming unit counts. Organs of interest were placed
in a 2 mL tube (Sarstedt #72.693.005) containing 1 mL ice-cold PBS and 1.0 mm
diameter Zirconia/Silica beads (Biospec Products #11079110z). Samples were
homogenized using a MagNA Lyzer (Roche) for 2 min at 6000 rpm. An aliquot of
each organ sample was serially diluted in PBS and plated on Todd-Hewitt Agar to
enumerate CFU.
Purification of biotinylated proteins. Biotinylated proteins were purified from
homogenized organs (3 mg protein) using a Bravo AssayMap platform and
AssayMap streptavidin cartridges (Agilent). Briefly, cartridges were prewashed with
50 mM ammonium bicarbonate (pH 8), and then samples were loaded. Non-
biotinylated proteins were removed by extensively washing the cartridges with 8M
urea in 50 mM ammonium bicarbonate buffer (pH 8). Cartridges were washed with
Rapid digestion buffer (Promega, Rapid digestion buffer kit) and bound proteins
were subjected to on-column digestion using mass spec grade Trypsin/Lys-C Rapid
digestion enzyme (Promega, Madison, WI) at 70 °C for 2 h. Released peptides were
desalted in the Bravo platform using AssayMap C18 cartridges and the organic
solvent was removed by vacuum centrifugation (SpeedVac). Samples were stored in
−20 °C prior to LC–MS/MS analysis.
LC–MS/MS analysis. Dried peptides were reconstituted with 2% acetonitrile, 0.1%
formic acid, and quantified by modified BCA peptide assay (Thermo Fisher Sci-
entific). Equal peptide amounts derived from each sample were injected and
analyzed by LC-MS/MS using a Proxeon EASY nanoLC system (Thermo Fisher
Scientific) coupled to a Q-Exactive Plus mass spectrometer (Thermo Fisher Sci-
entific). Peptides were separated using an analytical C18 Acclaim PepMap column
(0.075 × 500 mm, 2 µm; Thermo Scientific) equilibrated with buffer A (0.1% formic
acid in water) and eluted in a 93-min linear gradient of 2–28% solvent B (100%
acetonitrile) at a flow rate of 300 nL/min. The mass spectrometer was operated in
positive data-dependent acquisition mode. MS1 spectra were measured with a
resolution of 70,000, an automated gain control (AGC) target of 1e6 and a mass
range from 350 to 1700 m/z. Up to 12 MS2 spectra per duty cycle were triggered,
fragmented by higher energy collisional dissociation (HCD), and acquired with a
resolution of 17,500 and an AGC target of 5e4, an isolation window of 1.6 m/z and
a normalized collision energy of 25. Dynamic exclusion was enabled with duration
of 20 s.
2D-LC–MS/MS analysis. Dried samples were reconstituted in 0.1 M ammonium
formate pH ~10 and analyzed by 2D-LC–MS/MS using a 2D nanoACQUITY Ultra
Performance Liquid Chromatography (UPLC) system (Waters corp., Milford, MA)
coupled to a Q-Exactive Plus mass spectrometer (Thermo Fisher Scientific). Pep-
tides were loaded onto the first-dimension column, XBridge BEH130 C18
NanoEase (300 µm × 50 mm, 5 µm) equilibrated with solvent A (20 mM ammo-
nium formate, pH 10, first-dimension pump) at 2 µL/min. The first fraction was
eluted at 17% of solvent B (100% acetonitrile) for 4 min and transferred to the
second dimension Symmetry C18 trap column 0.180 × 20 mm (Waters corp.,
Milford, MA) using a 1:10 dilution with 99.9% second dimensional pump solvent A
(0.1% formic acid in water) at 20 µL/min. Peptides were then eluted from the trap
column and resolved on the analytical C18 Acclaim PepMap column (0.075 ×
500 mm, 2 µm particles; Thermo Scientific) at low pH by increasing the compo-
sition of solvent B (100% acetonitrile) from 1 to 38% (non-linear) over 96 min at
300 nL/min. Subsequent fractions were generated with increasing concentrations of
solvent B. The first-dimension fractions were eluted at 19.5, 22, 26, and 65% solvent
B, respectively. The mass spectrometer was operated in positive data-dependent
acquisition mode. MS1 spectra were measured with a resolution of 70,000, an AGC
target of 1e6 and a mass range from 350 to 1700 m/z. Up to 12 MS2 spectra per
duty cycle were triggered, fragmented by HCD, and acquired with a resolution of
17,500 and an AGC target of 5e4, an isolation window of 1.6 m/z and a normalized
collision energy of 25. Dynamic exclusion was enabled with duration of 20 s.
Mass spectrometry data analysis. MS Raw.files were processed in the MaxQuant
platform49 (version 1.6.1.0) and searched by the Andromeda search engine50
against the mouse UniProt FASTA database (downloaded 06–02–2017) and against
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a common contaminant database. Search parameters were set as follows: enzyme,
trypsin/LysC with up to 2 potential missed cleavages; fixed modifications, carba-
midomethyl on cysteines; variable modifications, oxidation of methionine and
acetylation of protein N-terminus; minimum peptide length, 7. The false discovery
rate (FDR) for both peptide and protein identifications was set to 1% and was
calculated by searching the MS/MS data against a reversed decoy database. Allowed
mass deviation for precursor ions was set to 5 ppm and for peptide fragments was
set to 20 ppm. Label-free quantifications (LFQ) was based on a minimum of 2
counts, minimum number of neighbors was set to 3 and average number of
neighbors was 6. The match between runs option was applied with a match time
window of 0.7 min and an alignment time window of 20 min.
Statistical analysis. Bioinformatics and statistical analysis of proteomics results
were conducted in the Perseus statistical suite (version 1.6.5.0)51 of the MaxQuant
computational platform. MaxQuant results were imported into Perseus and
identified hits were filtered based on number of peptides (>2) and number of MS/
MS scans for each peptide (>2). Missing values were addressed by requiring a cut-
off corresponding to 75% valid values in at least one group (infected+ biotin,
uninfected+ biotin, or PBS controls). Remaining missing values were imputed
from the normal distribution using a width of 0.3 and a down shift of 1.8. Control
samples from PBS-perfused samples were used to subtract the background, keeping
protein identifications in labeled samples displaying at least a 2-fold change
enrichment. Statistically significant changes between groups were assessed by two-
way analysis of variance (ANOVA) with a permutation-based false discovery rate
(FDR) for multiple test correction and truncation after 250 randomizations.
Hierarchical clustering was applied using Euclidean distances and preprocessing
with k-means. The statistical significance of the blood chemistry analysis was
determined using a two-tailed Student’s t-test in GraphPad prism (version 5.03).
Pathway and GO term analysis were conducted using the online version of
Metascape and DAVID server. Louvain clustering was performed in Python 3.6.6
using the python package python-Louvain located on the Python Package Index.
Clustering was done running default parameter settings.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The proteomics raw data and metadata have been deposited in the MassIVE archive
PXD013513. The source data underlying Figs. 4a, c, 7b and g are provided as a Source
Data file.
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